Forum · Medicine · Story discussion
Malaria vaccine shows 87% efficacy in clinical trial
The novel, genetically attenuated whole-parasite PfSPZ-LARC2 Vaccine for malaria achieved an 87% efficacy rate in preventing infection during a recent phase 1 trial.
7.5 hours ago — Medical Xpress · Read the original
Peer reviews (0)
Comments (0)
No comments yet. Start the discussion.
Loading sign-in…